Conceptual Background and Bioenergetic/Mitochondrial Aspects of Oncometabolism

Erscheinungsjahr 2014
ISBN: 978-0-12-416618-9
Verlag: William Andrew Publishing

Buch, Englisch, 536 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 1040 g

Volume 542 of Methods in Enzymology continues the legacy of this premier serial with quality chapters authored by leaders in the field. This new volume covers research methods providing a theoretical overview on metabolic alterations of cancer cells and a series of protocols that can be employed to study oncometabolism, in vitro, ex vivo and in vivo. Malignant cells exhibit metabolic changes when compared to their normal counterparts, owing to both genetic and epigenetic alterations. Although such a metabolic rewiring has recently been indicated as "yet another" general hallmark of cancer, accumulating evidence suggests that the metabolic alterations of each neoplasm rather represent a molecular signature that intimately accompanies, and hence cannot be severed from, all facets of malignant transformation.

Autoren/Hrsg.

Weitere Mitwirkende

Kroemer, Guido

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

1. The metabolic alterations of cancer cells 2. Autophagy and cancer metabolism 3. Regulation of cancer metabolism by oncogenes and tumor suppressors 4. Crosstalk between cell death regulation and metabolism 5. Techniques to monitor glycolysis 6. Measurement of enolase activity in cell lysates 7. Extracellular flux analysis to monitor glycolytic rates and mitochondrial oxygen consumption 8. Conventional techniques to monitor mitochondrial oxygen consumption 9. Combined high-resolution respirometry and fluorometry. Validation of safranin for determination of mitochondrial membrane potential. 10. Kinetic analysis of local oxygenation and respiratory responses of mammalian cells using intracellular oxygen-sensitive probes and time-resolved fluorescence plate reader 11. 13C isotope-assisted methods for quantifying glutamine metabolism in cancer cells 12. Measurement of fatty acid oxidation rates in animal tissues and cell lines 13. Methods to assess steroid hormone induced lipid accumulation in cancer cells 14.Use of chemical probes to monitor mitochondrial ROS production by fluorescence dyes for flow cytometry and spectrofluorometry 15. Rapid methods to monitor mitochondrial and cellular ROS production by fluorescence microscopy and fluorometry 16. Genetically encoded redox sensors in biomedical science 17. Real time measurement of metabolic states in living cells using genetically encoded NADH sensors 18. Use of genetically encoded sensors to monitor cytosolic ATP/ADP ratio in living cells 19.Methods to monitor and compare mitochondrial and glycolytic ATP production in cells 20. Measurement of ADP-ATP exchange in relation to membrane potential and oxygen consumption in mitochondria with improved calibration 21. Analysis of hypoxia-induced metabolic reprogramming

Über Autor(innen)

Kroemer, Guido
Guido Kroemer got his M.D. in 1985 from the University of Innsbruck, Austria, and his Ph.D. in molecular biology in 1992 from the Autonomous University of Madrid, Spain. He is currently Professor at the Faculty of Medicine of the University of Paris Descartes/Paris V, Director of the INSERM research team 'Apoptosis, Cancer and Immunity', Director of the Metabolomics and Cell Biology platforms of the Gustave Roussy Cancer Campus, and Practitioner at the Hôpital Européen George Pompidou (Paris, France). He is also the Director of the Paris Alliance of Cancer Research Institutes (PACRI) and the Labex 'Immuno-Oncology'. Dr. Kroemer is best known for the discoveries that mitochondrial membrane permeabilization constitutes a decisive step in regulated cell death; that autophagy is a cytoprotective mechanism with lifespan-extending effects; and that anticancer therapies are successful only if they stimulate tumour-targeting immune responses. He is currently the most-cited cell biologist in Europe (relative to the period 2007-2013), and he has received the Descartes Prize of the European Union, the Carus Medal of the Leopoldina, the Dautrebande Prize of the Belgian Royal Academy of Medicine, the Léopold Griffuel Prize of the French Association for Cancer Research, the Mitjavile prize of the French National Academy of Medicine and a European Research Council Advanced Investigator Award.